Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells
Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway ep...
Saved in:
| Published in | Immunology and cell biology Vol. 81; no. 4; pp. 289 - 296 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Nature Publishing Group
01.08.2003
Blackwell Science Ltd |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 ± 4.1% for chronic obstructive pulmonary disease versus 25.6 ± 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. |
|---|---|
| AbstractList | Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 ± 4.1% for chronic obstructive pulmonary disease versus 25.6 ± 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 +/- 4.1% for chronic obstructive pulmonary disease versus 25.6 +/- 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells.Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 +/- 4.1% for chronic obstructive pulmonary disease versus 25.6 +/- 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. SummaryChronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 ± 4.1% for chronic obstructive pulmonary disease versus 25.6 ± 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 plus or minus 4.1% for chronic obstructive pulmonary disease versus 25.6 plus or minus 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 +/- 4.1% for chronic obstructive pulmonary disease versus 25.6 +/- 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells. |
| Author | Hodge, Sandra Reynolds, Paul N Holmes, Mark Hodge, Greg Scicchitano, Raffaele |
| Author_xml | – sequence: 1 givenname: Sandra surname: Hodge fullname: Hodge, Sandra organization: Department of Medicine, University of Adelaide – sequence: 2 givenname: Greg surname: Hodge fullname: Hodge, Greg organization: Department of Haematology, Women's and Children's Hospital – sequence: 3 givenname: Raffaele surname: Scicchitano fullname: Scicchitano, Raffaele organization: Department of Medicine, University of Adelaide – sequence: 4 givenname: Paul N surname: Reynolds fullname: Reynolds, Paul N organization: Department of Medicine, University of Adelaide – sequence: 5 givenname: Mark surname: Holmes fullname: Holmes, Mark organization: Department of Medicine, University of Adelaide |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/12848850$$D View this record in MEDLINE/PubMed |
| BookMark | eNqVks1u1DAUhS1URKeFV0CWkLrL4Js4ibNBKlMKlYrYdG85zg3jkRMH2-l0HoZ3xWEKSN0AK0u-n879OeeMnIxuREIugK2B8ertbg2cswxqgHXOWLGODDLIGEDN1g_PyOp3-YSsmACRNRWHU3IWwo4xVueieEFOIRdciJKtyPdLe4_OKk8Hpb2btuorBtp7N9AwtzvUMdC9iVuqt96NRlPXhuhnHc090mm2gxuVP9DOBFQBqfJIO-yNNjhGakYat2g8Va2xJh5odHTp4PQhuoWe3BRdTKrK-L06UJxSK7RGWarR2vCSPO-VDfjq8T0nd9cf7jafstsvH282l7eZ5rzMsyLXyFrQvGoU012ZdoNc96KvO9DQYd2iwKZRkIp503Otij7xSvEKa1EX5-TiKDt5923GEOVgwjKAGtHNQdYFL1leVH8FQTRl2QAk8M0TcOdmP6YdJNSiEsAqyBP1-pGa2wE7OXkzpGvKX_Yk4N0RSNaE4LH_gzC55EHu5GK4XAyXSx5kyoME-TMP8iEJXD0R0CaqaNwYvTL232WujzJ7Y_Hwn0PIm8-b98s3z4sf08HX2A |
| CitedBy_id | crossref_primary_10_3346_jkms_2018_33_e56 crossref_primary_10_1124_jpet_115_223032 crossref_primary_10_1258_ebm_2010_010122 crossref_primary_10_1371_journal_pone_0220636 crossref_primary_10_1183_09031936_00190410 crossref_primary_10_1164_rccm_200807_1148OC crossref_primary_10_1371_journal_pone_0098571 crossref_primary_10_3389_fped_2017_00123 crossref_primary_10_1016_j_ejcdt_2014_11_030 crossref_primary_10_1128_IAI_00963_09 crossref_primary_10_1152_ajplung_00027_2013 crossref_primary_10_36106_gjra_3912068 crossref_primary_10_1038_s41598_018_31459_6 crossref_primary_10_1083_jcb_201004096 crossref_primary_10_3390_jcm6020021 crossref_primary_10_1513_AnnalsATS_201809_592MG crossref_primary_10_1007_s10495_008_0187_8 crossref_primary_10_1007_s11356_018_3344_9 crossref_primary_10_1007_s11033_012_1924_1 crossref_primary_10_1371_journal_pone_0121200 crossref_primary_10_1371_journal_pone_0122771 crossref_primary_10_1183_16000617_0126_2020 crossref_primary_10_1371_journal_pone_0056147 crossref_primary_10_1007_s10495_006_9527_8 crossref_primary_10_1002_jcla_20348 crossref_primary_10_1016_j_cyto_2012_07_022 crossref_primary_10_1007_s10753_016_0363_x crossref_primary_10_1002_jgf2_694 crossref_primary_10_4049_jimmunol_173_2_1033 crossref_primary_10_4049_jimmunol_1200984 crossref_primary_10_1371_journal_pone_0207675 crossref_primary_10_18632_aging_206129 crossref_primary_10_1016_j_cellimm_2016_11_009 crossref_primary_10_1164_rccm_200501_035OC crossref_primary_10_1183_09031936_00036709 crossref_primary_10_3389_fimmu_2023_1201658 crossref_primary_10_4049_jimmunol_1203330 crossref_primary_10_1038_s41467_021_26777_9 crossref_primary_10_2147_COPD_S266394 crossref_primary_10_1186_s12931_019_1142_7 crossref_primary_10_1165_rcmb_2012_0492TR crossref_primary_10_1128_IAI_01841_06 crossref_primary_10_1016_j_bj_2017_12_002 crossref_primary_10_1183_09031936_05_00077604 crossref_primary_10_1016_j_imlet_2022_07_005 crossref_primary_10_1111_j_1440_1843_2010_01914_x crossref_primary_10_1002_cyto_b_20020 crossref_primary_10_1164_rccm_201303_0434OC crossref_primary_10_1016_j_chest_2015_10_066 crossref_primary_10_1186_s12931_021_01718_8 crossref_primary_10_3389_fimmu_2021_720109 crossref_primary_10_1016_j_jceh_2014_08_003 crossref_primary_10_1016_j_tips_2007_11_002 crossref_primary_10_1096_fj_202000657R crossref_primary_10_1183_09031936_00193908 crossref_primary_10_1155_2016_2053646 crossref_primary_10_2147_copd_2006_1_2_161 crossref_primary_10_1152_ajplung_90569_2008 crossref_primary_10_1165_rcmb_2007_0306OC crossref_primary_10_1111_j_1440_1843_2012_02287_x crossref_primary_10_1016_j_ccm_2007_06_008 crossref_primary_10_1183_09031936_05_00110504 crossref_primary_10_1016_j_cyto_2013_09_010 crossref_primary_10_3389_fimmu_2021_659523 crossref_primary_10_1164_rccm_201601_0019LE crossref_primary_10_1016_j_jaci_2016_05_011 crossref_primary_10_3390_pathogens10020134 crossref_primary_10_1164_rccm_200711_1661OC crossref_primary_10_1111_resp_13696 crossref_primary_10_1152_physrev_00048_2006 crossref_primary_10_1159_000504344 crossref_primary_10_1016_j_stemcr_2016_06_011 crossref_primary_10_1038_s41598_020_68753_1 crossref_primary_10_1378_chest_13_0488 crossref_primary_10_3389_fmolb_2021_717038 crossref_primary_10_1177_1535370213494552 crossref_primary_10_1007_s12013_023_01187_4 crossref_primary_10_4049_jimmunol_174_12_8106 crossref_primary_10_1186_s12931_021_01722_y crossref_primary_10_1007_s10495_010_0490_z crossref_primary_10_1183_09031936_00128008 crossref_primary_10_1016_j_ymeth_2007_12_001 crossref_primary_10_1152_ajplung_00370_2020 crossref_primary_10_1177_117727190600100018 crossref_primary_10_2174_0113895575247690230926113455 crossref_primary_10_3389_fimmu_2016_00311 crossref_primary_10_1007_s00281_016_0555_3 crossref_primary_10_1371_journal_pone_0136455 crossref_primary_10_1016_j_imbio_2008_11_003 crossref_primary_10_1016_j_molimm_2014_04_006 crossref_primary_10_3389_fmed_2021_737859 crossref_primary_10_1186_1465_9921_15_72 crossref_primary_10_1038_mi_2015_120 crossref_primary_10_1016_j_freeradbiomed_2018_07_024 crossref_primary_10_4049_jimmunol_1402217 crossref_primary_10_1186_1465_9921_7_143 crossref_primary_10_1016_j_healun_2004_10_009 crossref_primary_10_1016_j_jad_2025_02_098 crossref_primary_10_1164_rccm_200711_1666OC crossref_primary_10_3109_08958378_2015_1070220 crossref_primary_10_3389_fimmu_2020_02179 crossref_primary_10_1165_rcmb_2003_0255OC crossref_primary_10_1177_0192623311428477 crossref_primary_10_1080_08958370490476604 crossref_primary_10_1186_1465_9921_11_46 crossref_primary_10_4049_jimmunol_1701417 crossref_primary_10_1016_j_tiv_2009_08_008 crossref_primary_10_1016_j_arr_2020_101235 crossref_primary_10_3389_fimmu_2024_1383503 crossref_primary_10_1189_jlb_0410205 crossref_primary_10_1111_resp_12949 crossref_primary_10_1371_journal_pone_0163139 crossref_primary_10_1186_s12931_020_01446_5 crossref_primary_10_3389_fimmu_2024_1404615 crossref_primary_10_1111_resp_12730 crossref_primary_10_1152_ajplung_00118_2024 crossref_primary_10_1183_13993003_02244_2018 crossref_primary_10_1172_JCI32709 crossref_primary_10_1038_nrm2970 crossref_primary_10_1183_13993003_00589_2023 crossref_primary_10_1513_AnnalsATS_201503_151AW crossref_primary_10_1371_journal_pone_0096720 crossref_primary_10_4137_JCD_S5375 crossref_primary_10_1038_nri3607 crossref_primary_10_1186_s12944_020_01278_8 crossref_primary_10_1371_journal_pone_0180143 crossref_primary_10_1080_08820139_2024_2334296 crossref_primary_10_1002_ppul_23351 crossref_primary_10_1007_s42485_022_00102_4 crossref_primary_10_1155_2018_2349045 crossref_primary_10_1038_s41598_021_82481_0 crossref_primary_10_1074_jbc_M110_137604 crossref_primary_10_1111_j_1440_1843_2012_02186_x crossref_primary_10_1016_j_pharmthera_2022_108282 crossref_primary_10_17816_brmma63652 crossref_primary_10_1042_CS20181009 crossref_primary_10_1164_rccm_201507_1376OC crossref_primary_10_2139_ssrn_3954720 crossref_primary_10_1042_CS20210099 crossref_primary_10_3390_biomedicines9121939 crossref_primary_10_1093_infdis_jit400 crossref_primary_10_1513_AnnalsATS_201305_123AW crossref_primary_10_1124_pr_111_004622 crossref_primary_10_1152_ajplung_00456_2018 crossref_primary_10_1371_journal_pone_0153336 crossref_primary_10_3109_01902140903578868 crossref_primary_10_1056_NEJMra0804752 crossref_primary_10_1517_14728214_2012_702755 crossref_primary_10_1016_S0300_2896_05_70740_7 crossref_primary_10_1186_s12931_020_1278_5 crossref_primary_10_1016_j_imlet_2009_12_017 crossref_primary_10_1016_j_ajpath_2011_09_029 crossref_primary_10_1016_j_febslet_2010_10_046 crossref_primary_10_1183_09031936_00109906 crossref_primary_10_1080_01902140802366261 crossref_primary_10_1165_rcmb_2008_0486OC crossref_primary_10_1016_j_niox_2020_06_003 crossref_primary_10_1016_j_compbiomed_2023_107685 crossref_primary_10_1164_rccm_201509_1838OC crossref_primary_10_3390_ijms22147634 crossref_primary_10_1016_j_rmed_2012_12_019 crossref_primary_10_1111_j_1365_2222_2012_04075_x crossref_primary_10_1007_s10753_017_0675_5 crossref_primary_10_1378_chest_129_6_1673 crossref_primary_10_1164_rccm_200808_1306OC crossref_primary_10_1183_23120541_00177_2024 crossref_primary_10_1016_j_bj_2017_09_004 crossref_primary_10_1165_rcmb_2017_0351LE crossref_primary_10_1038_ncomms8386 crossref_primary_10_2147_COPD_S246845 crossref_primary_10_20538_1682_0363_2011_6_52_56 crossref_primary_10_1586_17476348_2_3_329 crossref_primary_10_3390_ijms19020582 crossref_primary_10_1016_j_intimp_2022_108532 crossref_primary_10_1165_rcmb_2007_0002ED crossref_primary_10_1586_17476348_2_6_753 crossref_primary_10_1016_j_healun_2011_01_710 crossref_primary_10_3390_antiox11030464 crossref_primary_10_1186_1465_9921_13_101 crossref_primary_10_3390_cells12242771 crossref_primary_10_1152_ajplung_00185_2005 crossref_primary_10_1183_09031936_06_00126905 crossref_primary_10_4137_JCD_S10818 crossref_primary_10_1007_s10495_010_0504_x crossref_primary_10_1146_annurev_physiol_020518_114320 crossref_primary_10_1183_23120541_00130_2017 crossref_primary_10_1152_ajplung_00111_2013 crossref_primary_10_18093_0869_0189_2008_0_5_66_70 crossref_primary_10_1111_j_1365_2222_2004_02054_x crossref_primary_10_1186_1471_2466_14_112 crossref_primary_10_1152_ajplung_90270_2008 crossref_primary_10_1186_s12950_021_00286_4 crossref_primary_10_1016_j_ebiom_2024_104993 crossref_primary_10_1111_resp_12415 crossref_primary_10_1586_ers_10_85 crossref_primary_10_3390_ijms222011016 crossref_primary_10_1016_j_pharmthera_2020_107500 crossref_primary_10_1177_17534666211039769 crossref_primary_10_1183_13993003_02170_2016 crossref_primary_10_1371_journal_pone_0110056 crossref_primary_10_1378_chest_12_0930 crossref_primary_10_1183_09031936_00018908 crossref_primary_10_1111_jcmm_14419 crossref_primary_10_1016_j_bpj_2013_12_036 crossref_primary_10_1183_16000617_0241_2021 crossref_primary_10_1042_CS20160487 crossref_primary_10_1080_15412550600976868 crossref_primary_10_14348_molcells_2021_0058 crossref_primary_10_1371_journal_pone_0061573 crossref_primary_10_1517_14728214_2015_1021683 crossref_primary_10_1378_chest_11_2348 crossref_primary_10_1007_s10238_023_01105_1 crossref_primary_10_1111_imcb_12217 crossref_primary_10_1164_rccm_201705_0903OC crossref_primary_10_1164_rccm_200507_1152OC crossref_primary_10_1111_j_1440_1843_2012_02135_x crossref_primary_10_1177_0022034511421200 crossref_primary_10_1172_jci_insight_129259 crossref_primary_10_1097_MCP_0b013e32835cfff5 crossref_primary_10_1136_thoraxjnl_2020_216296 crossref_primary_10_3389_fmed_2023_1331000 crossref_primary_10_1517_13543784_14_8_997 crossref_primary_10_1155_2013_769214 crossref_primary_10_1186_1465_9921_7_53 crossref_primary_10_7124_bc_000957 crossref_primary_10_14814_phy2_13370 crossref_primary_10_1016_j_jaci_2019_07_015 crossref_primary_10_1016_j_jad_2024_02_022 crossref_primary_10_1081_COPD_200050676 crossref_primary_10_1183_09031936_06_00053906 crossref_primary_10_1007_s00018_024_05310_3 crossref_primary_10_3390_metabo14060317 crossref_primary_10_1038_s41420_022_01154_7 crossref_primary_10_1152_ajplung_00481_2007 crossref_primary_10_3390_ijms22020583 crossref_primary_10_1080_08916930701357208 crossref_primary_10_1038_s41580_020_0232_1 crossref_primary_10_1161_01_ATV_0000166517_18801_a7 crossref_primary_10_1189_jlb_3A1015_471R crossref_primary_10_3390_antiox12040973 crossref_primary_10_1186_2049_2618_1_19 crossref_primary_10_2147_COPD_S276792 crossref_primary_10_1155_2016_3845247 crossref_primary_10_1016_j_ijpharm_2013_11_042 crossref_primary_10_1371_journal_pone_0179577 crossref_primary_10_1080_15412550701603775 crossref_primary_10_3389_fimmu_2018_01777 crossref_primary_10_1016_j_jaci_2012_09_028 crossref_primary_10_1016_j_jim_2015_12_004 crossref_primary_10_1152_ajplung_00482_2021 crossref_primary_10_1378_chest_10_2281 crossref_primary_10_1111_cea_12159 crossref_primary_10_1183_09031936_06_00001506 crossref_primary_10_1152_ajplung_00518_2016 crossref_primary_10_1186_1465_9921_14_33 crossref_primary_10_3390_ijms21030853 crossref_primary_10_1165_rcmb_2004_0108OC crossref_primary_10_1080_15412555_2021_1978419 crossref_primary_10_1111_j_1365_2249_2011_04455_x crossref_primary_10_3109_15412555_2016_1153614 crossref_primary_10_1186_1465_9921_10_113 crossref_primary_10_1155_2018_9031452 crossref_primary_10_1081_COPD_120028701 crossref_primary_10_1016_j_ccm_2020_06_007 crossref_primary_10_1007_s10787_022_00967_3 crossref_primary_10_1016_j_taap_2012_05_024 crossref_primary_10_1042_CS20150273 crossref_primary_10_1152_japplphysiol_00519_2004 crossref_primary_10_1186_1465_9921_9_14 crossref_primary_10_3389_fmed_2022_832510 crossref_primary_10_1016_j_biocel_2021_105966 crossref_primary_10_1038_s41598_022_25520_8 crossref_primary_10_1016_j_rmedu_2009_10_020 crossref_primary_10_4236_alc_2013_22006 crossref_primary_10_1371_journal_pone_0051107 crossref_primary_10_1590_1414_431x20154730 crossref_primary_10_4049_jimmunol_176_12_7657 crossref_primary_10_1136_jim_2016_000358 crossref_primary_10_1016_j_intimp_2010_06_002 crossref_primary_10_1111_cns_13256 crossref_primary_10_3109_08958378_2011_576278 crossref_primary_10_1016_j_rmed_2009_01_011 crossref_primary_10_1152_ajplung_00116_2011 crossref_primary_10_1080_15412555_2018_1476475 crossref_primary_10_1111_j_1752_699X_2009_00157_x crossref_primary_10_1002_mrm_27999 crossref_primary_10_1155_2022_9300269 crossref_primary_10_1165_rcmb_2009_0459OC crossref_primary_10_15789_1563_0625_AAN_2482 crossref_primary_10_1002_jcp_26455 crossref_primary_10_1016_j_clim_2021_108913 crossref_primary_10_1016_j_ejphar_2011_12_026 crossref_primary_10_1189_jlb_0903439 crossref_primary_10_1016_j_ccm_2013_10_004 crossref_primary_10_1164_rccm_201511_2212ED crossref_primary_10_3390_toxics11060532 crossref_primary_10_1007_s00408_012_9438_0 crossref_primary_10_1152_ajplung_00290_2015 crossref_primary_10_1038_s41598_017_07101_2 crossref_primary_10_3389_fimmu_2016_00003 crossref_primary_10_1186_s40779_015_0039_0 crossref_primary_10_1016_j_lungcan_2012_01_017 crossref_primary_10_11150_kansenshogakuzasshi_89_56 crossref_primary_10_1164_rccm_202203_0482OC crossref_primary_10_1186_1465_9921_13_83 crossref_primary_10_1016_j_ecoenv_2021_113139 crossref_primary_10_1016_j_lfs_2020_118968 crossref_primary_10_1146_annurev_physiol_021119_034610 crossref_primary_10_1155_2017_3028082 crossref_primary_10_1165_rcmb_2007_0025OC crossref_primary_10_18093_0869_0189_2010_5_56_60 crossref_primary_10_1042_CS20191202 crossref_primary_10_1016_j_ijheh_2014_07_002 crossref_primary_10_3390_ijerph15051033 |
| Cites_doi | 10.1165/ajrcmb.17.3.2893 10.1378/chest.117.3.684 10.1182/blood.V93.4.1406 10.1172/JCI10259 10.1016/S1567-5769(01)00100-X 10.1007/BF00915894 10.1023/A:1020291617820 10.1172/JCI116578 10.1164/ajrccm.160.supplement_1.5 10.1083/jcb.124.4.619 10.1172/JCI116019 10.1172/JCI0213572 10.2307/3429709 10.1159/000196512 10.1046/j.1440-1711.2002.01120.x 10.1007/BF02631062 10.1016/S0022-1759(00)00233-7 10.1016/0091-6749(91)90189-U 10.1152/ajplung.2001.280.2.L369 10.1164/ajrccm.163.7.2002015 10.1002/cyto.a.10005 10.4049/jimmunol.161.11.6250 10.1172/JCI5628 10.1016/S1053-2498(99)00115-1 10.1007/BF00320205 10.1172/JCI9199 10.1016/0022-1759(87)90224-9 |
| ContentType | Journal Article |
| Copyright | 2003 Australasian Society for Immunology Inc. Copyright Nature Publishing Group Aug 2003 |
| Copyright_xml | – notice: 2003 Australasian Society for Immunology Inc. – notice: Copyright Nature Publishing Group Aug 2003 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7T5 H94 7X8 |
| DOI | 10.1046/j.1440-1711.2003.t01-1-01170.x |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection ProQuest Health & Medical Collection Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Immunology Abstracts AIDS and Cancer Research Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) AIDS and Cancer Research Abstracts Immunology Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic ProQuest Central Student AIDS and Cancer Research Abstracts MEDLINE CrossRef |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Biology |
| EISSN | 1440-1711 |
| EndPage | 296 |
| ExternalDocumentID | 4045026741 12848850 10_1046_j_1440_1711_2003_t01_1_01170_x IMCB200342 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Australian Lung Foundation – fundername: Royal Adelaide Hospital – fundername: Boehringer Ingelheim Chronic Airflow Limitation Research Fellowship |
| GroupedDBID | --- -Q- -~X .GJ 0R~ 1OB 1OC 29I 2WC 31~ 33P 36B 39C 3O- 3V. 4.4 53G 5RE 5VS 70F 7X7 88E 8FE 8FH 8FI 8FJ AAHHS AAHQN AAIPD AAMNL AANLZ AASGY AAXRX AAYCA AAZKR ABAWZ ABCUV ABJNI ABLJU ABQWH ABUWG ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACXBN ACXQS ADBBV ADBTR ADEOM ADFRT ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AENEX AEQDE AEUYR AEXYK AFEBI AFFPM AFGKR AFKRA AFPWT AFWVQ AFZJQ AGAYW AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE AJRNO ALIPV ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMYDB AOETA BBNVY BENPR BFHJK BHPHI BPHCQ BVXVI CAG CCPQU COF DCZOG DIK DRFUL DRMAN DRSTM DU5 E3Z EAS EBS EE. EHN EJD EMOBN ESX F5P FDQFY FUBAC FYUFA HCIFZ HGLYW HMCUK HZ~ IHE J5H JSO KBYEO KQ8 KTM LATKE LEEKS LH4 LK8 LUTES LW6 LYRES M1P M7P MEWTI MSFUL MSMAN MSSTM MVM MXFUL MXMAN MXSTM NAO O9- OBC OBS OK1 OVD P2P P2W PQQKQ PROAC PSQYO QN7 RJQFR RNS RNTTT ROL SAMSI SNX SUPJJ TEORI TR2 UKHRP W2D WH7 WOHZO WOQ WXSBR YFH ZGI ZXP ZZTAW ~02 ~KM AAYXX AEYWJ AGHNM AGYGG CITATION PHGZM PHGZT CGR CUY CVF ECM EIF NPM 7XB 8FK AZQEC DWQXO GNUQQ K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS 7T5 H94 7X8 |
| ID | FETCH-LOGICAL-c4452-32ce0b1c469a0cd548812cf8f7d1c1de7be8e99a10cd29f4ca3f0b1aa46e7873 |
| IEDL.DBID | 7X7 |
| ISSN | 0818-9641 |
| IngestDate | Tue Aug 05 11:01:49 EDT 2025 Fri Jul 11 09:58:11 EDT 2025 Fri Jul 25 11:55:41 EDT 2025 Wed Feb 19 02:42:18 EST 2025 Thu Apr 24 23:01:28 EDT 2025 Tue Jul 01 03:27:11 EDT 2025 Wed Jan 22 17:05:02 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4452-32ce0b1c469a0cd548812cf8f7d1c1de7be8e99a10cd29f4ca3f0b1aa46e7873 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| PMID | 12848850 |
| PQID | 1786810612 |
| PQPubID | 2041954 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_73450236 proquest_miscellaneous_18955911 proquest_journals_1786810612 pubmed_primary_12848850 crossref_primary_10_1046_j_1440_1711_2003_t01_1_01170_x crossref_citationtrail_10_1046_j_1440_1711_2003_t01_1_01170_x wiley_primary_10_1046_j_1440_1711_2003_t01_1_01170_x_IMCB200342 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | August 2003 2003-08-00 2003-Aug 20030801 |
| PublicationDateYYYYMMDD | 2003-08-01 |
| PublicationDate_xml | – month: 08 year: 2003 text: August 2003 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: London |
| PublicationTitle | Immunology and cell biology |
| PublicationTitleAlternate | Immunol Cell Biol |
| PublicationYear | 2003 |
| Publisher | Nature Publishing Group Blackwell Science Ltd |
| Publisher_xml | – name: Nature Publishing Group – name: Blackwell Science Ltd |
| References | 1996; 18 1987; 101 2001; 163 2003; 51A 1984; 49 2001; 280 2000; 117 1997; 155 1999; 23 1988; 12 1992; 28A 2002; 80 1999; 104 2001; 46 1994; 124 1992; 90 2000; 19 1993; 92 1991; 88 1999; 160 2000; 106 1984; 55 1997; 17 1996; 63 2000; 243 2001; 1 2002; 109 1999; 93 1998; 161 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_18_1 e_1_2_7_17_1 Ferrara F (e_1_2_7_11_1) 1996; 18 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_10_1 Pauwels RA (e_1_2_7_19_1) 2001; 46 e_1_2_7_26_1 e_1_2_7_27_1 Gibson P (e_1_2_7_29_1) 1997; 155 e_1_2_7_28_1 e_1_2_7_30_1 e_1_2_7_25_1 e_1_2_7_31_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 Immunol Cell Biol. 2003 Dec;81(6):499 |
| References_xml | – volume: 155 start-page: A296 year: 1997 article-title: Pulmonary macrophage phagocytosis of apoptotic neutrophils is mediated by thrombospondin and its receptors‐avb3 and CD36 publication-title: Am. J. Respir. Crit. Care Med. – volume: 92 start-page: 388 year: 1993 end-page: 97 article-title: Role of mesenchymal cell death in lung remodeling after injury publication-title: J. Clin. Invest. – volume: 55 start-page: 297 year: 1984 end-page: 306 article-title: Role of connective tissue proteases in the pathogenesis of chronic inflammatory lung disease publication-title: Environ. Health Perspect. – volume: 243 start-page: 167 year: 2000 end-page: 90 article-title: Flow cytometry of apoptotic cell death publication-title: J. Immunol. Meth. – volume: 88 start-page: 808 year: 1991 end-page: 14 article-title: Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases publication-title: J. Allergy Clin. Immunol. – volume: 93 start-page: 1406 year: 1999 end-page: 12 article-title: Previous uptake of apoptotic neutrophils or ligation of integrin receptors downmodulates the ability of macrophages to ingest apoptotic neutrophils publication-title: Blood – volume: 1 start-page: 1765 year: 2001 end-page: 76 article-title: Anti‐inflammatory effects of chemically modified tetracyclines by the inhibition of nitric oxide and interleukin‐12 synthesis in J774 cell line publication-title: Int. Immunopharmacol. – volume: 12 start-page: 87 year: 1988 end-page: 97 article-title: Comparative study of phagocytosis and intracellular bactericidal activity of human monocytes and polymorphonuclear cells. Application of fluorochrome and extracellular quenching technique publication-title: Inflammation – volume: 23 start-page: 63 year: 1999 end-page: 73 article-title: Neutrophils injure bronchial epithelium after ozone exposure publication-title: Inflammation – volume: 124 start-page: 619 year: 1994 end-page: 26 article-title: Disruption of epithelial cell‐matrix interactions induces apoptosis publication-title: J. Cell Biol. – volume: 161 start-page: 6250 year: 1998 end-page: 7 article-title: CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3) publication-title: J. Immunol. – volume: 17 start-page: 272 year: 1997 end-page: 8 article-title: Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen publication-title: Am. J. Respir. Cell Mol. Biol. – volume: 163 start-page: 1578 year: 2001 end-page: 83 article-title: Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferon) publication-title: Am. J. Respir. Crit. Care Med. – volume: 18 start-page: 109 year: 1996 end-page: 14 article-title: The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease publication-title: Int. J. Tissue React. – volume: 90 start-page: 1513 year: 1992 end-page: 22 article-title: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis publication-title: J. Clin. Invest. – volume: 109 start-page: 661 year: 2002 end-page: 70 article-title: Elastase‐mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis publication-title: J. Clin. Invest. – volume: 80 start-page: 537 year: 2002 end-page: 43 article-title: Up‐regulation of production of TGF‐beta and IL‐4 and down‐regulation of IL‐6 by apoptotic human bronchial epithelial cells publication-title: Immunol. Cell Biol. – volume: 63 start-page: 28 year: 1996 end-page: 34 article-title: Bombesin enhances monocyte and macrophage activities: possible role in the modulation of local pulmonary defenses in chronic bronchitis publication-title: Respiration – volume: 117 start-page: 684 year: 2000 end-page: 94 article-title: Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD publication-title: Chest – volume: 19 start-page: 160 year: 2000 end-page: 6 article-title: Apoptosis and formation of peroxynitrite in the lungs of patients with obliterative bronchiolitis publication-title: J. Heart Lung Transplant – volume: 160 start-page: S12 year: 1999 end-page: S16 article-title: Inflammation and repair processes in chronic obstructive pulmonary disease publication-title: Am. J. Respir. Crit. Care Med. – volume: 51A start-page: 7 year: 2003 end-page: 15 article-title: Phagocytosis of apoptotic cells by human macrophages: Analysis by multiparameter flow cytometry publication-title: Cytometry – volume: 104 start-page: 13 year: 1999 end-page: 19 article-title: Essential roles of the Fas‐Fas ligand pathway in the development of pulmonary fibrosis publication-title: J. Clin. Invest. – volume: 280 start-page: L369 year: 2001 end-page: L375 article-title: Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma publication-title: Am. J. Physiol. Lung Cell Mol. Physiol. – volume: 106 start-page: 1311 year: 2000 end-page: 19 article-title: Inhibition of VEGF receptors causes lung cell apoptosis and emphysema publication-title: J. Clin. Invest. – volume: 106 start-page: 25 year: 2000 end-page: 35 article-title: T cell‐mediated Fas‐induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis publication-title: J. Clin. Invest. – volume: 28A start-page: 735 year: 1992 end-page: 44 article-title: A transformed human epithelial cell line that retains tight junctions post crisis publication-title: In Vitro Cell Dev. Biol. – volume: 49 start-page: 315 year: 1984 end-page: 23 article-title: Phagocyte C3‐mediated attachment and internalization: flow cytometric studies using a fluorescence quenching technique publication-title: Blut. – volume: 101 start-page: 119 year: 1987 end-page: 25 article-title: The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation publication-title: J. Immunol. Meth. – volume: 46 start-page: 798 year: 2001 end-page: 825 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary publication-title: Respir. Care – ident: e_1_2_7_5_1 doi: 10.1165/ajrcmb.17.3.2893 – ident: e_1_2_7_10_1 doi: 10.1378/chest.117.3.684 – ident: e_1_2_7_31_1 doi: 10.1182/blood.V93.4.1406 – ident: e_1_2_7_6_1 doi: 10.1172/JCI10259 – ident: e_1_2_7_25_1 doi: 10.1016/S1567-5769(01)00100-X – ident: e_1_2_7_23_1 doi: 10.1007/BF00915894 – ident: e_1_2_7_27_1 doi: 10.1023/A:1020291617820 – ident: e_1_2_7_3_1 doi: 10.1172/JCI116578 – ident: e_1_2_7_2_1 doi: 10.1164/ajrccm.160.supplement_1.5 – volume: 18 start-page: 109 year: 1996 ident: e_1_2_7_11_1 article-title: The macrophagic activity of patients affected by pneumonia or chronic obstructive pulmonary disease publication-title: Int. J. Tissue React. – ident: e_1_2_7_26_1 doi: 10.1083/jcb.124.4.619 – ident: e_1_2_7_30_1 doi: 10.1172/JCI116019 – ident: e_1_2_7_7_1 doi: 10.1172/JCI0213572 – ident: e_1_2_7_24_1 doi: 10.2307/3429709 – ident: e_1_2_7_12_1 doi: 10.1159/000196512 – ident: e_1_2_7_18_1 doi: 10.1046/j.1440-1711.2002.01120.x – ident: e_1_2_7_16_1 doi: 10.1007/BF02631062 – volume: 46 start-page: 798 year: 2001 ident: e_1_2_7_19_1 article-title: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: National Heart, Lung, and Blood Institute and World Health Organization Global Initiative for Chronic Obstructive Lung Disease (GOLD): executive summary publication-title: Respir. Care – ident: e_1_2_7_17_1 doi: 10.1016/S0022-1759(00)00233-7 – ident: e_1_2_7_20_1 doi: 10.1016/0091-6749(91)90189-U – ident: e_1_2_7_14_1 doi: 10.1152/ajplung.2001.280.2.L369 – ident: e_1_2_7_13_1 doi: 10.1164/ajrccm.163.7.2002015 – ident: e_1_2_7_15_1 doi: 10.1002/cyto.a.10005 – ident: e_1_2_7_28_1 doi: 10.4049/jimmunol.161.11.6250 – volume: 155 start-page: A296 year: 1997 ident: e_1_2_7_29_1 article-title: Pulmonary macrophage phagocytosis of apoptotic neutrophils is mediated by thrombospondin and its receptors‐avb3 and CD36 publication-title: Am. J. Respir. Crit. Care Med. – ident: e_1_2_7_4_1 doi: 10.1172/JCI5628 – ident: e_1_2_7_8_1 doi: 10.1016/S1053-2498(99)00115-1 – ident: e_1_2_7_22_1 doi: 10.1007/BF00320205 – ident: e_1_2_7_9_1 doi: 10.1172/JCI9199 – ident: e_1_2_7_21_1 doi: 10.1016/0022-1759(87)90224-9 – reference: - Immunol Cell Biol. 2003 Dec;81(6):499 |
| SSID | ssj0007283 |
| Score | 2.2337565 |
| Snippet | Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and... SummaryChronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 289 |
| SubjectTerms | Aged alveolar macrophage Antibodies, Monoclonal Apoptosis bronchial epithelial cell Bronchoalveolar Lavage Fluid - cytology Bronchoalveolar Lavage Fluid - immunology Cell Line, Transformed Cell Survival Epithelial Cells - cytology Epithelial Cells - immunology Epithelial Cells - physiology Flow Cytometry Humans Macrophages, Alveolar - immunology Phagocytosis Pulmonary Disease, Chronic Obstructive - etiology Pulmonary Disease, Chronic Obstructive - immunology Respiratory Mucosa - cytology Respiratory Mucosa - immunology |
| Title | Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1046%2Fj.1440-1711.2003.t01-1-01170.x https://www.ncbi.nlm.nih.gov/pubmed/12848850 https://www.proquest.com/docview/1786810612 https://www.proquest.com/docview/18955911 https://www.proquest.com/docview/73450236 |
| Volume | 81 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nb9QwEB1BKyouCMpXoBQfELfAOnHi-ICqtmpVkLZCqEh7ixzHEZWWJGyyhfwY_iszjrMVIBBcoki2Eycz9szz2G8AXlRpUalUIzaRCV5EGYeq4DzU6ItEeBPrhA4Kz8_Ts4_i3SJZ-AW3zm-rnOZEN1GXjaE18tdcZkSdhQb5oP0SUtYoiq76FBo3YZuoy2hLl1xsANdMRiMNJxqlUKWC78DLX6OakjuQGL_qEVYTsOZyNtEgTUbqN8_zZ0fWWaLTu3DHu5DscJT5Pbhh6124NSaVHHZhZ-7D5ffh--HyyhJ2ZZ81per6hJNHx-hECevWBa3AdIwWYpkZKXJZU3g-2SvL2vUSv1mvBuaDOEyvLCstUU6gpWKXNXNRBjYyfQ-sbxi9oTFD31Dttmn7BvvI9OXqqx6Yben8xxIVnlG4oHsAF6cnF8dnoc_HEBohkiiMI2NnBTeIqPXMlIh10DswVVbJkhteWlnYzCqlORZGqhJGxxXW11qkFueF-CFs1U1tHwMj0jWjqiiJdCaSUmRJIXSiVKXoqWkVwJvp_-fGc5VTyoxl7mLmInWYReA9yo8yacY5yi_nuZNf_i0AuWnfjqwd_9xybxJ37kdzl1_rXgDPN8U4Dulv6do2a6yTEZcf53-uIWOREF9_AI9GNbruGvoIWZbMAjhwevWffc7fzo-PIkfm-OTv3X8Kt91mRLeBcQ-2UKXsM3Sq-mLfjZx92D46OX__4Qd2dhxK |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwEB6VrShcUCl_Cy31AbgF1onzd6iqtrTapd0VQovUm-U4jqi0JGGz25KH4RF4R2acZCtAIDj0EkWKk1ie8cx8HvsbgBdZkGRxoBCbhD5eROo5ccK5ozAWcfHGUz4dFB5PguFH8e7cP1-D791ZGNpW2dlEa6jTQtMa-RseRkSdhQ55v_ziUNUoyq52JTQatTg19RVCtmpv9Bbl-9J1T46nR0OnrSrgaCF81_FcbQYJ14gL1UCnGLGjj9NZlIUp1zw1YWIiE8eK40M3zoRWXobtlRKBQe328LO3YF14iGR6sH54PHn_YWX6Q7fh_UQv6MSB4Bvw6tc0asgtKvVeLxDHE5Ln4aDjXeq84m-h7s-Rs3V9J5twr41Z2UGjZPdhzeRbcLupYllvwca4zc8_gG8Hs0tDYJl9VlQb7BNaq4rRERZWLRNa8qkYrfwy3XDysiJpCWwvDSuXMxxkNa9ZmzViam5YaojjAl0ju8iZTWuwhlq8ZouC0R8KXS8Kal0W5aLAPjJ1Mb9SNTMlHTiZ4QxjlJ-oHsL0JkT1CHp5kZsnwIjlTceZ67sqEn4qIj8Ryo_jLKavBlkf9rrxl7olR6caHTNpk_QisCBJ4D3Kj0p3ehLlJ7m08pNf-xCu3i8bmpB_fnO7E7dszUclr5W9D7urxzjxabRUbooltomIPJDzP7cIPeFTgYA-PG7U6LprGJREkT_ow77Vq__ssxyNjw5dyx759O_d34U7w-n4TJ6NJqfP4K7dCWl3T25DD9XL7GBEt0iet_OIgbzhmfsD7PpZPw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alveolar+macrophages+from+subjects+with+chronic+obstructive+pulmonary+disease+are+deficient+in+their+ability+to+phagocytose+apoptotic+airway+epithelial+cells&rft.jtitle=Immunology+and+cell+biology&rft.au=Hodge%2C+Sandra&rft.au=Hodge%2C+Greg&rft.au=Scicchitano%2C+Raffaele&rft.au=Reynolds%2C+Paul+N&rft.date=2003-08-01&rft.pub=Nature+Publishing+Group&rft.issn=0818-9641&rft.eissn=1440-1711&rft.volume=81&rft.issue=4&rft.spage=289&rft.epage=296&rft_id=info:doi/10.1046%2Fj.1440-1711.2003.t01-1-01170.x&rft.externalDBID=10.1046%252Fj.1440-1711.2003.t01-1-01170.x&rft.externalDocID=IMCB200342 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0818-9641&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0818-9641&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0818-9641&client=summon |